Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...
Formation Bio today announced that Anirvan Ghosh, PhD, has joined the company as SVP, Head of Translational Sciences. Ghosh ...
The new NCCN Guidelines for the Philippines reflect close collaborations between NCCN and PSMO, as well as with the Society ...
Dean Merder to serve as Executive Advisor to the Chairman, following eight years of leadership. WASHINGTON, Ind.--(BUSINESS ...
With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.
The collaboration brings Evergreen's care management and operational capabilities together with Vitality's physician-led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results